Results 61 to 70 of about 927,073 (74)

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann S De Bono
exaly  

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly  

Increased cancer burden among pesticide applicators and others due to pesticide exposure

Ca-A Cancer Journal for Clinicians, 2013
Matthew R Bonner, Demosthenes Bouros
exaly  

Breast cancer and circadian disruption from electric lighting in the modern world

Ca-A Cancer Journal for Clinicians, 2014
George C Brainard, Steven W Lockley
exaly  

Early integration of palliative care services with standard oncology care for patients with advanced cancer

Ca-A Cancer Journal for Clinicians, 2013
Joseph A Greer
exaly  

Disparities in liver cancer occurrence in the United States by race/ethnicity and state

Ca-A Cancer Journal for Clinicians, 2017
Farhad Islami, Rebecca L Siegel, Ahmedin Jemal   +2 more
exaly  

An assessment of progress in cancer control

Ca-A Cancer Journal for Clinicians, 2018
Ted Gansler, Rebecca L Siegel, Ahmedin Jemal   +2 more
exaly  

Physical activity counseling in primary care: Insights from public health and behavioral economics

Ca-A Cancer Journal for Clinicians, 2017
Kerem Shuval, Tammy Leonard, David L Katz   +2 more
exaly  

Pharmacogenetics and pharmacogenomics of anticancer agents

Ca-A Cancer Journal for Clinicians, 2009
R Stephanie Huang
exaly  

Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association

Ca-A Cancer Journal for Clinicians, 2004
Robert A Smith, Evandro Novaes
exaly